S
Hoji Alimi
Founder, President, and CEO, Oculus Innovative Sciences
SECRET TO HIS SUCCESS: Conviction
FAVE MOVIE: Gladiator—"It shows the importance of the greater good"
Hoji Alimi, whose father was a general in the Iranian army, was exiled as a teen when the Shah was desposed. "Life wasn't handed to me on a silver platter," he says. He became a microbiologist, honing his skills at AVE (bought by Medtronic) as a biologist and toxicologist. While pursuing his master's degree, he found a promising cancer compound—but his professor refused the data, which contradicted other findings. Alimi used it to found Micromet Labs.
Hoji Alimi
"My wife and I wanted to buy a house," he says. "I told her, we could buy it and that would be our life—or we could take this opportunity. She said to go for it or I'd regret it for the rest of my life."
Another compound soon caught Alimi's attention. An investor sent him a liquid shown to induce rapid wound healing. "For four years, I worked by day at Micromet and then would stay up trying to reformulate the product to be stable. People asked when I was going to give up."
But Alimi didn't give up, and has since shown Microcyn, as trademarked, to be more effective than levofloxicin at helping burn patients leave the hospital, and is effective against drug-resistant bacteria. Now this wound care solution is marketed around the world—and just completed Phase II trials in the US.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Recent Developments in Pharmaceutical Validation
November 1st 2024Explore the latest pharmaceutical validation developments with industry experts from Barry-Wehmiller Design Group, Kneat Solutions, and No Deviation. You’ll gain valuable data-driven insights and discover emerging trends from the State of Validation 2024 industry report that are shaping the validation landscape.